These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 12032582)
21. [Immunomodulatory effects of intravenous immunoglobulins]. Kazatchkine M; Mouthon L; Kaveri SV Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983 [TBL] [Abstract][Full Text] [Related]
22. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know? Crow AR; Lazarus AH Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251 [TBL] [Abstract][Full Text] [Related]
23. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465 [TBL] [Abstract][Full Text] [Related]
24. High-dose intravenous immunoglobulin G treatment of myasthenia gravis. Ferrero B; Durelli L Neurol Sci; 2002 Apr; 23 Suppl 1():S9-24. PubMed ID: 12032583 [TBL] [Abstract][Full Text] [Related]
31. Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy. Gerstenblith MR; Antony AK; Junkins-Hopkins JM; Abuav R J Am Acad Dermatol; 2012 Feb; 66(2):312-6. PubMed ID: 21601310 [TBL] [Abstract][Full Text] [Related]
32. Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms. Wong PH; White KM Clin Rev Allergy Immunol; 2016 Dec; 51(3):303-314. PubMed ID: 26142065 [TBL] [Abstract][Full Text] [Related]
33. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases. Hurez V; Kaveri SV; Kazatchkine MD J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249 [TBL] [Abstract][Full Text] [Related]
34. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. Rütter A; Luger TA J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915 [TBL] [Abstract][Full Text] [Related]
36. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation. Jordan SC; Toyoda M; Vo AA Expert Rev Clin Immunol; 2011 May; 7(3):341-8. PubMed ID: 21595600 [TBL] [Abstract][Full Text] [Related]
37. What's new in i.v. immunoglobulin therapy and pemphigus: high-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus. Aoyama Y J Dermatol; 2010 Mar; 37(3):239-45. PubMed ID: 20507387 [TBL] [Abstract][Full Text] [Related]
38. [Immunoglobulins and rules of passive-active prophylaxis]. Bucholc B Przegl Epidemiol; 2003; 57(2):391-7. PubMed ID: 12910611 [TBL] [Abstract][Full Text] [Related]
39. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Bayry J; Dasgupta S; Misra N; Ephrem A; Duong Van Huyen JP; Delignat S; Hassan G; Caligiuri G; Nicoletti A; Lacroix-Desmazes S; Kazatchkine MD; Kaveri S Int Immunopharmacol; 2006 Apr; 6(4):528-34. PubMed ID: 16504915 [TBL] [Abstract][Full Text] [Related]
40. History of immunoglobulin replacement. Eibl MM Immunol Allergy Clin North Am; 2008 Nov; 28(4):737-64, viii. PubMed ID: 18940572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]